1. Altered treatment of chronic lymphocytic leukemia in Germany during the last decade

   • Anna-Katharina Zoellner
   • Thomas Höhler
   • Martin Dreyling

   Original Article 29 March 2016 Pages: 853 - 861

   

2. Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome

   • Giuseppe Carli
   • Carlo Visco
   • Francesco Rodeghiero

   Original Article 22 March 2016 Pages: 863 - 870

   

3. Bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal single-center study

   • Christian Kjellander
   • Magnus Björkholm
   • Sigurdur Y. Kristinsson

   Original Article 15 March 2016 Pages: 871 - 879

   

4. miR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosis

   • Marcela Cristina Robaina
   • Roberta Soares Faccion
   • Claudete Esteves Klumb

   Original Article 05 April 2016 Pages: 881 - 891

   

5. Central nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trial

   • E. González-Barca
   • M. Canales
   • on behalf of the GELTAMO group

   Original Article Open access 30 March 2016 Pages: 893 - 899

   

6. Clinicopathological characteristics and outcomes of light chain deposition disease: an analysis of 48 patients in a single Chinese center

   • Xiao Mei Li
   • Hao Chen Rui
   • Cai Hong Zeng

   Original Article 08 April 2016 Pages: 901 - 909

   

7. The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea

   • Ho Sup Lee
   • Chang-Ki Min
   • The Korean Multiple Myeloma Working Party (KMMWP)

   Original Article 06 April 2016 Pages: 911 - 919

   

8. Reduced frequency treatment with bortezomib plus dexamethasone for elderly patients with relapsed and/or refractory multiple myeloma: a phase 2 study of the Japanese Myeloma Study Group (JMSG-0902)

   • Shuji Ozaki
   • Hiroyuki Hata
   • Kazuyuki Shimizu

   Original Article 05 April 2016 Pages: 921 - 929

   

9. Lenalidomide is effective and safe for the treatment of patients with relapsed multiple myeloma and very severe renal impairment

   • Cristina João
   • José Freitas
   • Graça V. Esteves

   Original Article 11 April 2016 Pages: 931 - 936

10. Causes of death in 2877 patients with myelodysplastic syndromes

    • Kathrin Nachtkamp
    • Romina Stark
    • Ulrich Germing

    Original Article 30 March 2016 Pages: 937 - 944

    

11. Distinct mechanisms account for acquired von Willebrand syndrome in plasma cell dyscrasias

    • Christina Dicke
    • Sonja Schneppenheim
    • Florian Langer

    Original Article 04 April 2016 Pages: 945 - 957

    

12. Abnormalities of the bone marrow immune microenvironment in patients with immune thrombocytopenia

    • Yang Song
    • Yu-Tong Wang
    • Yuan Kong

    Original Article 18 March 2016 Pages: 959 - 965

    

13. Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study

    • Alois Gratwohl
    • Simona Iacobelli
    • for the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation EBMT

    Original Article 19 March 2016 Pages: 967 - 972

    

14. Allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A single center experience

    • Joerg U. Schmohl
    • Christiane Groh
    • Wolfgang A. Bethge

    Original Article 28 March 2016 Pages: 973 - 983

    

15. Genotyping of 22 blood group antigen polymorphisms and establishing a national recipient registry in the Korean population

    • Yun Ji Hong
    • Yousun Chung
    • Kyou Sup Han

    Original Article 28 March 2016 Pages: 985 - 991

16. East Mediterranean region sickle cell disease mortality trial: retrospective multicenter cohort analysis of 735 patients

    • Pelin Kardaş Karacaoglu
    • Suheyl Asma
    • Hakan Ozdogu

    Original Article 12 April 2016 Pages: 993 - 1000

17. Outcome of empirical or targeted antifungal therapy after antifungal prophylaxis in febrile neutropenia

    • C. Hahn-Ast
    • L. Felder
    • M. von Lilienfeld-Toal

    Original Article 28 March 2016 Pages: 1001 - 1009

    

18. Paraneoplastic limbic encephalitis in B cell lymphoma unclassifiable with features intermediate between diffuse large B cell lymphoma and classical Hodgkin lymphoma

    • Kazutoshi Ebisawa
    • Junji Koya
    • Mineo Kurokawa

    Letter to the Editor 17 March 2016 Pages: 1011 - 1012

    

19. New mechanism of lymphoma-induced bone marrow aplasia

    • Antonio Pierini
    • Antonella Mancusi
    • Andrea Velardi

    Letter to the Editor 09 March 2016 Pages: 1013 - 1015

    

20. Alveolar rhabdomyosarcoma mimicking Burkitt-like lymphoma

    • Emmanuel Benayoun
    • Bouchra Badaoui
    • Orianne Wagner-Ballon

    Letter to the Editor 22 March 2016 Pages: 1017 - 1018

    

21. Unusual co-occurrence of Hodgkin lymphoma and hemophagocytic lymphohistiocytosis in a bone marrow aspirate

    • M. Ángeles Domínguez-Muñoz
    • Rosario M. Morales-Camacho
    • Juan José Borrero

    Letter to the Editor 28 March 2016 Pages: 1019 - 1021

    

22. Mismatched unrelated hematopoietic stem cell transplantation with post-transplant cyclophosphamide for high-risk acute myeloid leukemia

    • Sarah Lindner
    • Tobias Berg
    • Gesine Bug

    Letter to the Editor 08 April 2016 Pages: 1023 - 1025

23. Continuous molecular remission and regression of side effects after discontinuation of salvage therapy with sorafenib and donor lymphocyte infusions in a young patient with relapsed AML

    • Jana Ernst
    • Vivien Schäfer
    • Bernd Gruhn

    Letter to the Editor 16 March 2016 Pages: 1027 - 1030